Rare antibodies with potential to combat alpha-gal syndrome identified

National Institutes of Health (NIH) researchers person discovered uncommon antibodies that could pass the improvement of an involution for alpha-gal syndrome (AGS), an emerging tick bite-associated information that tin pb to allergic reactions to a molecule successful reddish nutrient and different carnal products. In laboratory tests, these antibodies acted arsenic a biologic shield, blocking quality allergic antibodies from binding to reddish nutrient allergens. The findings were published successful the Journal of Clinical Investigation.